Quantum Laser Leader Prepares for STAR Market Listing

Frequency Precision Laser Technology Co., Ltd., a prominent player in China's quantum-precision laser sector, has officially announced its listing date on the Shanghai Stock Exchange's STAR Market. Trading is set to commence on August 18, 2026.

Offering Details and Financials

The company plans a public offering of 10 million new shares, priced at 186.88 yuan per share. Post-listing, its total share capital will reach 40 million shares. Approximately 7.62 million shares will be unrestricted and tradable initially, representing 19.04% of the total equity.

Financially, the company reported robust performance for 2025, with annual revenue of 418 million yuan and a net profit of 151 million yuan.

End-to-End Core Technology Portfolio

Founded in November 2017, Frequency Precision Laser has built a formidable technological moat. Its core competence lies in mastering the entire precision laser chain—from seed sources and fiber amplification to nonlinear frequency conversion and frequency stabilization. This integrated capability enables the company to deliver laser outputs across a broad spectrum from 177 nm to 5000 nm, featuring narrow linewidth, low noise, and high power.

Dual Growth Engines: Quantum and Semiconductors

The company's products address critical needs in two high-growth, technology-intensive fields.

  • Quantum Technology: Its high-precision lasers serve as key components in quantum computing and quantum metrology, providing essential light sources for qubit manipulation and readout.
  • Semiconductor Manufacturing: In wafer fabrication, metrology, inspection, and stealth dicing processes, the company's advanced laser systems support the industry's push towards finer and more precise manufacturing.

Strategic Use of IPO Proceeds

The net proceeds from the IPO will be strategically allocated. Primary uses include funding the industrialization project for precision laser systems, enhancing the capabilities of the company's main R&D center, and establishing a new R&D center in Wuhan to strengthen regional research efforts. A portion will also supplement working capital to support ongoing operations and future growth initiatives.